Office on Women's Health

The Worldwide Assisted Reproductive Technology Industry is Expected to Reach $12 + Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 17, 2021
Health, Women, Consumer, Other Health, Polycystic ovary syndrome, FET, Uterus, GIFT, Cryo, American Society for Reproductive Medicine, Office on Women's Health, CAGR, Awareness, Woman, Disease, Centers for Disease Control and Prevention, ART, Infertility, Prevalence, IVD, Zygote intrafallopian transfer, Assisted reproductive technology, PCOS, TMRW, Male, Egg, Family, Fertilisation, Fertility clinic, Female, Software, OWH, Obesity, Risk, Center, Incidence, Society, Knowledge, Women's health, End user, CDC, IVF, Growth, Renewable energy, Birth control, Agriculture

The "Assisted Reproductive Technology Market by Product, Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Assisted Reproductive Technology Market by Product, Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to ResearchAndMarkets.com's offering.
  • The global assisted reproductive technology market was valued at $2,317.7 million in 2020, and is estimated to reach $12,272.5 million by 2030, growing at a CAGR of 19.3% from 2021 to 2030.
  • Assisted reproductive technology (ART) is defined as the medical procedure used to address the infertility treatments for handling of eggs and embryo.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global assisted reproductive technology market.

STARS Tackles Opioid Misuse With National Campaign

Retrieved on: 
Thursday, June 20, 2019
Mental health, Teens, Women, Managed care, Pharmaceutical, Consumer, Health, Office on Women's Health, Women's health, Opioid, RTT

STARS , a 2017 recipient of a grant from the Office on Womens Health (OWH), launched its opioid misuse prevention campaign, Have The Conversation , last year and has recently expanded outreach to include video livestreams.

Key Points: 
  • STARS , a 2017 recipient of a grant from the Office on Womens Health (OWH), launched its opioid misuse prevention campaign, Have The Conversation , last year and has recently expanded outreach to include video livestreams.
  • STARS weekly livestreams host industry professionals to discuss issues related to identifying opioid misuse with loved ones and having conversations that ultimately lead to recovery.
  • Have the Conversation is a statewide and national campaign led by STARS Nashville aimed at empowering individuals to have a conversation about opioid misuse.
  • STARS is an evidence-based, award-winning nonprofit with a national footprint in clinical, behavioral and mental health services.